Lv51
1427 积分 2024-05-13 加入
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
2小时前
已完结
Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma
3小时前
已完结
Systematic literature review of the global burden of illness of mantle cell lymphoma
3小时前
已完结
Tailored approaches in mantle cell lymphoma: refining treatment paradigms with an expert panel opinion
1天前
已完结
Population Pharmacokinetics of the BTK Inhibitor Acalabrutinib and its Active Metabolite in Healthy Volunteers and Patients with B-Cell Malignancies
3天前
已完结
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study
8天前
已完结
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
10天前
已完结
Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)
12天前
已完结
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial
12天前
已完结
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
15天前
已完结
皖公网安备34019202002308
